Literature DB >> 16868596

A prospective analysis of intrathecal granuloma in chronic pain patients: a review of the literature and report of a surveillance study.

Timothy R Deer1.   

Abstract

BACKGROUND: Over the past decade granulomas have been noted to occur at or near the tip of intrathecal catheters used for spinal infusions. The majority of cases involved morphine infusions, although other drugs have been implicated. Granulomas may be asymptomatic or cause significant neurological deficits.
METHODS: Consecutive patients with intrathecal infusions were examined for the presence of intrathecal granulomas. MRI or CT was used to make the diagnosis.
RESULTS: A total of 208 patients underwent imaging over a period of 34 weeks. Six patients (3%) were found to have a significant lesion. Five of the six patients were asymptomatic and one patient complained of radicular pain in the distribution of the catheter tip. The average catheter infusion time for patients with granulomas was 27 months, not significantly different from patients without granulomas. No specific characteristics, such as drugs or concentrations were identified. All six patients had percutaneous catheter revisions without complication.
CONCLUSION: Intrathecal granulomas were identified in 3% of patients imaged in this series. Eighty percent of the patients were asymptomatic. MRI imaging remains the diagnostic method of choice for most patients, and can be done safely when scans are taken at the level of the catheter tip. Given the low incidence of granulomas with intrathecal catheters, routine imaging to identify granulomas is not warranted.

Entities:  

Year:  2004        PMID: 16868596

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  7 in total

1.  Intrathecal catheter tip inflammatory mass lesions (granulomas): a case report with bone destruction and review of imaging findings.

Authors:  Beril Gok; Mohammadreza Hayeri; Richard Kanoff; Michael Brooks
Journal:  Emerg Radiol       Date:  2012-07-06

Review 2.  Intrathecal Analgesia for Chronic Refractory Pain: Current and Future Prospects.

Authors:  Catherine Smyth; Nadera Ahmadzai; Jason Wentzell; Ashley Pardoe; Andrew Tse; Tiffany Nguyen; Yvette Goddard; Shona Nair; Patricia A Poulin; Becky Skidmore; Mohammed T Ansari
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

Review 3.  The Proteomics of Intrathecal Analgesic agents for Chronic Pain.

Authors:  David M Moore; Connail McCrory
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

4.  Pre- and Post-Interventional Changes in Physiological Profiles in a Patient Presenting With Opioid Withdrawal After Intrathecal Drug Delivery System Failure Related to Assumed Catheter Microfracture.

Authors:  Reza Ehsanian; Eugene Koshkin; Aleyah E Goins; Marena A Montera; Sascha Alles
Journal:  Cureus       Date:  2021-05-04

5.  Spinal cord compression secondary to intrathecal catheter-induced granuloma: a report of four cases.

Authors:  Paul M Arnold; Viraat Harsh; Seth M Oliphant
Journal:  Evid Based Spine Care J       Date:  2011-02

6.  Intrathecal pump catheter-tip granuloma recurrence with associated myelomalacia - How safe is intrathecal analgesic infusion therapy? A case report.

Authors:  Moritz Haering; Christian Saleh; Phillip Jaszczuk; Markus Koehler; Margret Hund-Georgiadis
Journal:  Surg Neurol Int       Date:  2019-04-24

7.  Targeted Drug Delivery for Chronic Nonmalignant Pain: Longitudinal Data From the Product Surveillance Registry.

Authors:  David M Schultz; Alaa Abd-Elsayed; Aaron Calodney; Katherine Stromberg; Todd Weaver; Robert J Spencer
Journal:  Neuromodulation       Date:  2021-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.